Affymetrix Settles Investor Suit to Push Ahead with eBioscience Acquisition
January 31, 2012
Affymetrix Settles Investor Suit to Push Ahead with eBioscience Acquisition
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- As Affymetrix Tries to Salvage Deal, eBioscience Explores Other Options
February 29, 2012 / GenomeWeb Daily News - Affymetrix Sued over Pending eBioscience Deal; Firm Pushes Back Acquisition Date
January 3, 2012 / BioArray News - Despite Continued Genotyping Growth, Weak Expression Sales Force Affymetrix to Suspend Guidance
May 7, 2013 / BioArray News - At JP Morgan, Affy Provides Update on Cyto FDA Submission, New Genotyping Products, Restructuring
January 15, 2013 / BioArray News - Analysts, Investors 'Troubled' as Affymetrix's Preliminary Q3 Revenues Miss Estimates
October 9, 2012 / BioArray News